U.S. Food and Drug Administration | Total Product Lifecycle Advisory Program (TAP) Engagement with Device Developers @US_FDA | Uploaded 2 weeks ago | Updated 16 minutes ago
In this lecture, Dr. Jeff Shuren, former Director of FDA’s Center for Devices and Radiological Health, explains how TAP is intended to help spur rapid development and more widespread patient access to safe, effective, high quality medical devices of public health importance. The TAP Pilot, launched in January 2023, offers the opportunity for device developers to be connected with key patient groups, provider groups and payers, so that they can develop the best strategy for how to get from concept to commercialization as efficiently as possible.
In this lecture, Dr. Jeff Shuren, former Director of FDA’s Center for Devices and Radiological Health, explains how TAP is intended to help spur rapid development and more widespread patient access to safe, effective, high quality medical devices of public health importance. The TAP Pilot, launched in January 2023, offers the opportunity for device developers to be connected with key patient groups, provider groups and payers, so that they can develop the best strategy for how to get from concept to commercialization as efficiently as possible.
